Literature DB >> 2079573

Hepatitis delta: the virus and the disease.

M Rizzetto1.   

Abstract

In general, the biological and structural properties of the hepatitis delta virus resemble those of the viroids and related satellite RNA viruses of plants. This resemblance has been strengthened by the discovery that, in analogy to the self-cleaving of some plant RNA viruses, hepatitis delta virus RNA possesses autocleaving and autoligating sites located in sequences that are homologous with highly conserved domains in the viroids. The catalytic properties identify the hepatitis delta virus as the first mammalian ribozyme. The current interpretation of the pathobiology of delta hepatitis rests on the postulates that the hepatitis delta virus invariably requires hepatitis B virus for infection and is highly pathogenic. Accordingly, delta hepatitis is thought to occur when hepatitis delta virus coinfects with hepatitis B virus or when it superinfects hepatitis B virus carriers. However, new evidence from the liver transplantation model suggests that hepatitis delta virus is capable of establishing latent, asymptomatic infections without the apparent assistance of hepatitis B virus: in this model, disease was only reactivated when hepatitis B virus also returned to the graft. Thus, hepatitis B virus superinfection on a latent hepatitis delta virus state may be a third pathobiological mechanism conducive to delta hepatitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079573     DOI: 10.1016/0168-8278(90)90183-r

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Differential effect of chronic hepatitis D virus infection on intrahepatic expression of hepatitis B viral antigen.

Authors:  J Y Lau; B C Portmann; G J Alexander; R Williams
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis.

Authors:  L H Simpson; M Battegay; J H Hoofnagle; J G Waggoner; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

3.  Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.

Authors:  Seyed-Moayed Alavian; Seyed Vahid Tabatabaei; Bita Behnava; Mario Rizzetto
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

4.  Development and evaluation of a baseline-event-anticipation score for hepatitis delta.

Authors:  B Calle Serrano; A Großhennig; M Homs; B Heidrich; A Erhardt; K Deterding; J Jaroszewicz; B Bremer; A Koch; M Cornberg; M P Manns; M Buti; H Wedemeyer
Journal:  J Viral Hepat       Date:  2014-03-27       Impact factor: 3.728

5.  Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in "Isolated anti-HBc" Antibodies Profile in Central Tunisia.

Authors:  Salma Mhalla; Yosr Kadri; Sana Alibi; Amel Letaief; Jalel Boukadida; Naila Hannachi
Journal:  Hepat Mon       Date:  2016-01-16       Impact factor: 0.660

6.  Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.

Authors:  Maria Buti; Maria Stepanova; Adriana Palom; Mar Riveiro-Barciela; Fatema Nader; Luisa Roade; Rafael Esteban; Zobair Younossi
Journal:  JHEP Rep       Date:  2021-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.